Drug development

InnoPharmax Inc.
9F, No. 22, Ln. 478, Ruiguang Rd, Neihu Dist, Taipei 11492, Taiwan
因華生技製藥股份有限公司
+886-2-8797-7607
+886-2-8797-5627

Focus on drug delivery technology platforms for improving the safety and efficacy of currently available drugs, particularly oncology drugs.

11492台北市內湖區瑞光路478巷22號9F
2005
– na –
Intech Biopharm Ltd.
3F, No. 36, Ln. 358, Ruiguang Rd, Neihu Dist, Taipei 114, Taiwan
益得生技股份有限公司
+886-2-7721-8877
+886-2-7721-8800

Drug R&D and manufacturing, also inhalers manufacturing technology

114台北市內湖區瑞光路358巷36號3F
2010
6461
TPEx Emerging
JHL Biotech Inc.
3F, No. 18, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County 302, Taiwan
喜康生物醫藥有限公司
+886-3-658-3899
+886-3-658-9567

Contract manufacturer, biologics / biosimilars developer

302新竹縣竹北市生醫路2段18號3F
2012
6540
TPEx
Lin BioScience, Inc.
​12F, No. 68, Sec. 5, Zhongxiao E. Rd,
Xinyi Dist, Taipei 110, Taiwan
仁新醫藥股份有限公司
+886-2-8780-5008

Drug development company. Pipeline of four drugs in preclinical stage: LBS-008 for Dry AMD; LBS-007 for Acute Leukemia; and LBS-002 and LBS-003 for oncology applications.

LBS-002 was acquired from the University of Sydney in March 2017, and has shown an ability to cross the blood-brain barrier with the potential for treating both primary and metastatic brain cancers.

110台北市信義區忠孝東路五段68號12F
2016
– na –
Lumosa Therapeutics Co., Ltd.
4F, No. 3-2, Park St, Nangang Dist, Taipei 11503, Taiwan
順天醫藥生技股份有限公司
+886-2-2655-7918
+886-2-2655-7919

Research and development of novel drugs for neurological and inflammatory diseases. Subsidiary of botanical drug company Sun Ten Pharmaceuticals.

台北市11503南港區園區街3-2號4F
2000
6535
TPEx
Medigen Biotechnology Corp.
14F, No. 3, Park St., Nangang Dist., Taipei 11503, Taiwan
基亞生物科技股份有限公司
+886-2-7736-1234
+886-2-7736-1233

Drug development, particularly for cancer, vaccines, IV diagnostics, generic drugs. Has three subsidiaries: Medigen Vaccine Biologics Corporation, TBG Diagnostics Limited, and Winston Medical & Biotech Group.

11503台北市南港區園區街3號F棟14F
1999
3176
TPEx
Meridigen Biotech Co., Ltd.
7F, No. 68, Sec. 1, Neihu Rd, Neihu Dist, Taipei City 11493, Taiwan
宣捷生物科技股份有限公司
+886-2-2627-5175
+886-2-2627-5275

Mesenchymal stem cells (MSCs) research and drug development, as well as diagnostic techniques and drug screening platform through partnerships.

11493台北市內湖區內湖路1段68號7F
2011
– na –
Mycenax Biotech Inc.
4F, No. 50-7, Keyan Rd, Zhunan Township, Miaoli County 35053, Taiwan
永昕生物醫藥股份有限公司
+886-3- 758-6988
+886-3-758-6188

Biologics Contract Manufacturing Organization (CMO) and developer of biosimilars. Products include: TuNEX®(etanercept), LusiNEX (tocilizumab), AiNEX (bevacizumab), GranNEX (G-CSF), Omalizumab, Adalimumab, Trastuzumab.

苗栗縣竹南鎮科研路50-7號4F
– na –
OBI Pharma, Inc.
Ste W1907, 19F, No. 3, Park St, Nankang Software Park,
Taipei, 11503, Taiwan
台灣浩鼎生技股份有限公司
+886-2-2655-8799
+886-2-2655-7790

R&D expertise in developing novel cancer and infectious disease therapies. Lead product in development is OBI-822, a first-in-class active immunotherapy for metastatic breast cancer. The company is also the license holder for DIFICID in Taiwan and owns the commercial rights to the product, a novel antibiotic indicated for C. difficile-associated diarrhea.

台北市南港園區街3號F棟19F, W1907室
2002
4174
TPEx
Oneness Biotech Co., Ltd.
3F, No. 3, Sec. 1, Dunhua S. Rd, Songshan Dist, Taipei 105, Taiwan
合一生技股份有限公司
+886-2-2570-2088
+886-2-2577-7618

New drugs developed from botanical sources. Lead drug is ON101 for diabetic foot ulcer healing, currently in end-phase clinical trials. Also OB318 for liver cancer, US FDA IND status obtained.

105台北市敦化南路1段3號3F
2008
4743
TPEx